Delivery Order SPE2DB20D2104-SPE2DB24FT60H
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,170.87, is for the delivery of 4,563,198,346 units of Mesalamine 800 mg delayed-release tablets. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical....
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Mesalamine delayed-release tablets, a pharmaceutical product used to treat certain gastrointestinal conditions. The contract has a ceiling value of $1,020.93 and a completion date of January 31, 2024. This contract was awarded as a delivery order under a larger Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of Mesalamine 800 mg delayed-release tablets to the Defense Logistics Agency (DLA), a defense agency. The $2,026.42 firm fixed-price delivery order contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of April 29, 2024. The contract award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,608.15 firm fixed-price delivery order, with a completion date of December 28, 2021, is for the supply of Mesalamine DR 1.2 GM Tablet 120S, a prescription medication. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of Mesalamine DR 1.2 GM tablets, with a total ceiling value of $3,889.79 and a completion date of December 4, 2023. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider registered with the System for Award Management (SAM.gov). Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., has a significant Indefinite Delivery Contract (IDC) with the Defense...
- This federal contract award, with the ID SPE2DX15D7067|SPE2DX24F2XND, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Mesalamine DR 1.2 GM Tablets in 120-count bottles, with a ceiling value of $3,655.02 and a completion date of January 31, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Mesalamine DR 1.2 GM tablets. The contract has a ceiling value of $4,072.15 and a completion date of April 4, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. Both Amerisourcebergen Drug Corp and Cencora, Inc. are for-profit organizations...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the procurement of Mesalamine delayed-release tablets. The contract has a firm fixed price of $13,369.15 and an ultimate completion date of December 17, 2021. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which serves as a critical supplier of pharmaceutical products and medical supplies to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,214.44, is for the delivery of 180 tablets of Mesalamine 800 mg delayed-release tablets. The contract does not have a set-aside designation, indicating it was awarded through open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Mesalamine delayed-release tablets. The contract, valued at $3,679.63, has a completion date of September 20, 2023 and is a Firm Fixed Price Delivery Order. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FT60HDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Mesalamine 800 mg delayed-release (DR) tablets. The contract has a ceiling value of $9,424.34 and an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which is a for-profit organization registered in the System for Award Management (SAM.gov). This contract award is not designated as a set-aside, indicating open competition. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.4k | 4/12/24 |